Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Goosehead Insurance (GSHD) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Goosehead Insurance (GSHD) over the last 9 years, with Q3 2025 value amounting to $3.7 million.

  • Goosehead Insurance's Capital Expenditures rose 1398.71% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 541.43%. This contributed to the annual value of $11.2 million for FY2024, which is 4547.7% up from last year.
  • Goosehead Insurance's Capital Expenditures amounted to $3.7 million in Q3 2025, which was up 1398.71% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Goosehead Insurance's Capital Expenditures ranged from a high of $9.2 million in Q3 2022 and a low of -$4.6 million during Q4 2022
  • For the 5-year period, Goosehead Insurance's Capital Expenditures averaged around $2.7 million, with its median value being $2.7 million (2024).
  • Within the past 5 years, the most significant YoY rise in Goosehead Insurance's Capital Expenditures was 364089.07% (2022), while the steepest drop was 20184.33% (2022).
  • Goosehead Insurance's Capital Expenditures (Quarter) stood at $4.6 million in 2021, then tumbled by 201.84% to -$4.6 million in 2022, then surged by 165.93% to $3.1 million in 2023, then decreased by 10.33% to $2.7 million in 2024, then skyrocketed by 35.13% to $3.7 million in 2025.
  • Its Capital Expenditures was $3.7 million in Q3 2025, compared to $2.9 million in Q2 2025 and $2.8 million in Q1 2025.